AstraZeneca signed a deal with Alteogen worth up to $1.35 billion for subcutaneous cancer drugs. Taiho Pharmacetical bought ...

What drew you to pursue a career in oncology and what is it that inspires you most about working in this field?

Shares of Abbott Laboratories advanced 3.74% to $131.35 Thursday, on what proved to be an all-around poor trading session for ...

Developers of cardiology drugs and devices will be back in the spotlight this weekend when the annual scientific meeting of ...

CHICAGO -- Semaglutide further solidified its efficacy for diabetes-associated cardiovascular conditions, this time building ...

Pfizer—the maker of Paxlovid—has begun ... instead of making lots of compounds and profiling them in the laboratory, which is a slower process. For example, Allerton says, their models can ...

A new precision oncology paper was published in Oncotarget, Volume 16, on March 12, 2025, titled “Worldwide Innovative ...

The vaccine protects against the serotypes responsible for the majority of adult invasive pneumococcal disease ...

Currently chief information officer at Quest Diagnostics, Fonseca will join Pfizer’s executive leadership team in January. Fonseca previously served as senior vice president at Laboratory ...

Population-based analyses of new vaccination programmes provide robust real-world evidence for post-licensure vaccine ...

Elevai Labs (NASDAQ:ELAB – Get Free Report) and Arvinas (NASDAQ:ARVN – Get Free Report) are both small-cap multi-sector conglomerates companies, but which is the superior business? We will compare the ...

Adolescents with alopecia areata achieve hair regrowth with 80% or more of scalp coverage while taking the Janus kinase inhibitor baricitinib, a phase 3 study finds.